We have previously shown that the mortality of patients with recurrent affective disorders in long-term lithium treatment is not higher than that of the general population.
In the present study on 471 patients from Denmark and Germany, we examined mortality during the initial year of lithium treatment and during later lithium treatment.
During initial lithium treatment, the total mortality was twice as high as in the general population (difference not significant) and the mortality due to suicide 16 times higher.
During later lithium treatment, the mortality rates did not differ from those in the general population.
Our results indicate that patients with frequent, often severe recurrences, those chosen for prophylactic lithium treatment, are at risk of high mortality, which then diminishes as the prophylactic action of the treatment takes effect.
Mots-clés Pascal : Trouble humeur, Prévention, Récidive, Etude longitudinale, Chimiothérapie, Traitement, Lithium, Psychotrope, Mortalité, Facteur risque, Suicide, Homme, Epidémiologie
Mots-clés Pascal anglais : Mood disorder, Prevention, Relapse, Follow up study, Chemotherapy, Treatment, Lithium, Psychotropic, Mortality, Risk factor, Suicide, Human, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0657595
Code Inist : 002B02B02. Création : 09/06/1995.